Montelukast Sodium Tablet
Product Images NDC 16571-100

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 16571-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (21b0f1b6 9603 4620 8d26 016b126bb88a 01)

FDA Label Image

Image (21b0f1b6 9603 4620 8d26 016b126bb88a 02)

FDA Label Image

Image (21b0f1b6 9603 4620 8d26 016b126bb88a 03)

Image (21b0f1b6 9603 4620 8d26 016b126bb88a 03)
Montelukast Sodium Tablets helps to prevent asthma and relieve symptoms like itching, sneezing, runny nose, and wheezing. It contains 10.4 mg of Montelukast Sodium equivalent to 10 mg Montelukast. This medicine is recommended for adults of 15 years or older. The usual dosage can be checked through the package insert. It should be stored at 25°C (77°F) and protected from light and moisture. The manufacturer is Graviti Pharmaceuticals Pvt. Ltd, Telangana-502307, INDIA, and it is distributed by Rising Pharma Holdings, Inc., East Brunswick, NJ 08816. The product is packed with 90 tablets.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.